• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Freedom From Stent Fracture-Related Complications of Vascular Longitudinal Remodeling in a Patient With Heart Failure and a Degraded Bioresorbable Vascular Scaffold.心力衰竭和生物可吸收血管支架降解患者血管纵向重塑后免于支架断裂相关并发症。
Tex Heart Inst J. 2023 Jan 1;50(1). doi: 10.14503/THIJ-21-7732.
2
Chronic Total Occlusion 5 Years After Bioresorbable Vascular Scaffold Implantation: A Serial Optical Coherence Tomography Assessment.生物可吸收血管支架置入 5 年后的慢性完全闭塞：一项连续光学相干断层扫描评估。
J Invasive Cardiol. 2020 May;32(5):E141. doi: 10.25270/jic/19.00428.
3
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years.随机比较依维莫司洗脱生物可吸收支架与金属支架：3 年多模态成像。
JACC Cardiovasc Interv. 2020 Jan 13;13(1):116-127. doi: 10.1016/j.jcin.2019.09.047.
4
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).植入可吸收依维莫司洗脱完全生物可吸收血管支架后急性支架断裂和晚期结构不连续性的发生率和影像学结果：ABSORB 队列 B 试验的光学相干断层成像评估（生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变患者的临床评价）。
JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016.
5
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.第二代生物可吸收依维莫司药物洗脱血管支架治疗冠状动脉原发狭窄的临床和影像学 6 个月随访结果。
Circulation. 2010 Nov 30;122(22):2301-12. doi: 10.1161/CIRCULATIONAHA.110.970772. Epub 2010 Nov 15.
6
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial.在 ABSORB II 试验中，生物可吸收依维莫司洗脱支架和金属依维莫司洗脱支架的术后对称性、扩张和偏心对临床结果的影响。
JACC Cardiovasc Interv. 2016 Jun 27;9(12):1231-1242. doi: 10.1016/j.jcin.2016.03.027. Epub 2016 Jun 1.
7
Is the Metallic Stent a Safe Treatment for Bioresorbable Scaffold Failure?: Insights From Optical Coherence Tomography.金属支架是生物可吸收支架失败的安全治疗方法吗？：来自光学相干断层扫描的见解。
JACC Cardiovasc Interv. 2016 May 9;9(9):976-7. doi: 10.1016/j.jcin.2016.02.031. Epub 2016 Apr 13.
8
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.依维莫司洗脱生物可吸收血管支架与依维莫司洗脱金属支架的比较：随机对照试验的荟萃分析。
Lancet. 2016 Feb 6;387(10018):537-544. doi: 10.1016/S0140-6736(15)00979-4. Epub 2015 Nov 17.
9
Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).使用三维光学相干断层成像术对生物可吸收血管支架封闭的分支血管进行 5 年的连续评估：来自 ABSORB 队列 B 试验的观察结果（生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变患者的临床评估）。
Circ Cardiovasc Interv. 2017 Sep;10(9). doi: 10.1161/CIRCINTERVENTIONS.116.004393.
10
Disruption of bioresorbable vascular scaffold struts due to loss of radial integrity: insights from optical coherence tomography.由于径向完整性丧失导致的生物可吸收血管支架支柱断裂：光学相干断层扫描的见解
Int J Cardiovasc Imaging. 2017 Mar;33(3):311-312. doi: 10.1007/s10554-016-1013-y. Epub 2016 Nov 10.

本文引用的文献

1
2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy.2 年随访：Absorb 生物可吸收支架治疗冠状动脉疾病：7 项随机临床试验的系统评价和荟萃分析及一项个体化患者数据分析亚研究。
Lancet. 2017 Aug 19;390(10096):760-772. doi: 10.1016/S0140-6736(17)31470-8. Epub 2017 Jul 18.
2
OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold.经皮冠状动脉介入治疗后 5 年的依维莫司洗脱生物可吸收血管支架的长期血管愈合反应的 OCT 评估。
J Am Coll Cardiol. 2014 Dec 9;64(22):2343-56. doi: 10.1016/j.jacc.2014.09.029. Epub 2014 Dec 1.
3
Meta-analysis of incidence, clinical characteristics and implications of stent fracture.支架断裂的发生率、临床特征及意义的荟萃分析。
Am J Cardiol. 2010 Oct 15;106(8):1075-80. doi: 10.1016/j.amjcard.2010.06.010.
4
Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis.药物洗脱支架在人体冠状动脉中骨折的发生率及预测因素：一项病理分析
J Am Coll Cardiol. 2009 Nov 17;54(21):1924-31. doi: 10.1016/j.jacc.2009.05.075.
5
Drug-eluting stent fracture and acute coronary syndrome.药物洗脱支架断裂与急性冠状动脉综合征
Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):166-71. doi: 10.1016/j.carrev.2009.02.003.

心力衰竭和生物可吸收血管支架降解患者血管纵向重塑后免于支架断裂相关并发症。

Freedom From Stent Fracture-Related Complications of Vascular Longitudinal Remodeling in a Patient With Heart Failure and a Degraded Bioresorbable Vascular Scaffold.

机构信息

Cardiovascular Division, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.

Cardiovascular Division, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.

出版信息

Tex Heart Inst J. 2023 Jan 1;50(1). doi: 10.14503/THIJ-21-7732.

DOI:10.14503/THIJ-21-7732
PMID:36735605
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9969783/
Abstract

Because vascular geometric change during the long-term process of cardiac chamber remodeling in heart failure is usually unpredictable after coronary stenting, the risk of acquired metallic stent fracture can persist. This rare but possible complication could be minimized with the implantation of bioresorbable vascular scaffold because of its unique properties. Here, the authors report on 1 patient with heart failure who received optical coherence tomography evaluation between 3 and 3.5 years after bioresorbable vascular scaffold implantation. Measurement of the discernible struts of bioresorbable vascular scaffold provided evidence of coronary longitudinal remodeling without serious risk of complications related to metallic stent fracture resulting from cardiac remodeling.

摘要

由于心力衰竭中心脏室重构过程中血管几何形状的变化通常是不可预测的，因此在冠状动脉支架置入后仍存在获得性金属支架断裂的风险。这种罕见但可能的并发症可以通过植入生物可吸收血管支架来最小化，因为它具有独特的特性。在这里，作者报告了 1 例心力衰竭患者，在生物可吸收血管支架植入后 3 至 3.5 年接受了光学相干断层扫描评估。生物可吸收血管支架可识别支架的测量结果提供了冠状动脉纵向重塑的证据，而没有与心脏重塑相关的金属支架断裂严重并发症的风险。